As of 2024-12-15, the EV/EBITDA ratio of Moberg Pharma AB (publ) (MOB.ST) is -8.23. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MOB.ST's latest enterprise value is 170.24 mil SEK. MOB.ST's TTM EBITDA according to its financial statements is -20.69 mil SEK. Dividing these 2 quantities gives us the above MOB.ST EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |
| 2024-12-13 | -8.23 |
| 2024-12-12 | -5.27 |
| 2024-12-11 | -5.89 |
| 2024-12-10 | -20.26 |
| 2024-12-09 | -20.19 |
| 2024-12-06 | -20.75 |
| 2024-12-05 | -20.19 |
| 2024-12-04 | -21.65 |
| 2024-12-03 | -20.61 |
| 2024-12-02 | -23.13 |
| 2024-11-29 | -25.75 |
| 2024-11-28 | -24.77 |
| 2024-11-27 | -24.70 |
| 2024-11-26 | -26.35 |
| 2024-11-25 | -27.74 |
| 2024-11-22 | -26.70 |
| 2024-11-21 | -28.85 |
| 2024-11-20 | -26.63 |
| 2024-11-19 | -25.63 |
| 2024-11-18 | -24.89 |
| 2024-11-15 | -22.25 |
| 2024-11-14 | -19.73 |
| 2024-11-13 | -20.45 |
| 2024-11-12 | -21.23 |
| 2024-11-11 | -19.17 |
| 2024-11-08 | -22.85 |
| 2024-11-07 | -20.54 |
| 2024-11-06 | -17.42 |
| 2024-11-05 | -14.18 |
| 2024-11-04 | -12.32 |
| 2024-11-01 | -12.02 |
| 2024-10-31 | -13.76 |
| 2024-10-30 | -13.85 |
| 2024-10-29 | -13.13 |
| 2024-10-28 | -12.23 |
| 2024-10-25 | -11.51 |
| 2024-10-24 | -10.29 |
| 2024-10-23 | -9.71 |
| 2024-10-22 | -9.22 |
| 2024-10-21 | -9.15 |
| 2024-10-18 | -11.17 |
| 2024-10-17 | -10.96 |
| 2024-10-16 | -10.70 |
| 2024-10-15 | -12.23 |
| 2024-10-14 | -12.63 |
| 2024-10-11 | -12.37 |
| 2024-10-10 | -11.28 |
| 2024-10-09 | -10.47 |
| 2024-10-08 | -8.60 |
| 2024-10-07 | -8.92 |